ResultsIQ

ResultsIQ › Latest results › Privi Speciality Chemicals Limited

Privi Speciality Chemicals Limited Q2 FY27 results deck summary

NSE: PRIVISCL · BSE: 530117

Results deck of 30 Oct 2026, summarised by AI from the filing.

Management targets ₹5,000 cr revenue and ₹1,000 cr+ EBITDA by FY29-30, with EBITDA margins expected to sustain north of 20%.

Key takeaways

  1. Vision target Management targets ₹5,000 cr revenue and ₹1,000 cr+ EBITDA by FY29-30, with EBITDA margins expected to sustain north of 20%.
  2. Expansion timeline Expansion projects are progressing as planned and will be ready for commercial operations in second half of 2028.
  3. Growth driver New products are expected to expand the addressable market and deepen customer relationships, alongside China+1 and existing product expansion.
  4. Headwinds Management flags difficult global headwinds, against which it says the business model stayed resilient.

Original filing on BSE

Privi Speciality Chemicals Limited Q2 FY27 results

As filed: Revenue ₹760 cr (+12% year on year), EBITDA ₹200 cr (+10% year on year), PAT ₹118 cr (+31% year on year), EBITDA margin 26.3% (−53 bps).

The Q2 FY27 score, against the company's own trend, is for premium members.

Earlier results and the share price after them

  • Q1 FY27: Revenue ₹666 cr (+19% year on year), EBITDA ₹152 cr (+15% year on year), PAT ₹82.8 cr (+43% year on year), EBITDA margin 22.9% (−76 bps). Score 40 of 100, In line with trend. Revenue and profit growth were below the company's own trend; EBITDA growth was well below it. EBITDA margin fell 76 bps year on year. Revenue fell 8% from last quarter. Revenue rose ₹107 cr on a year ago, more than the ₹95.0 cr it added the year before. Share price after the results: −6.7% in 29 days (Nifty 500: +0.8%).
  • Q4 FY26: Revenue ₹722 cr (+18% year on year), EBITDA ₹180 cr (+36% year on year), PAT ₹94.1 cr (+47% year on year), EBITDA margin 25.0% (+332 bps). Score 47 of 100, In line with trend. Revenue, EBITDA and profit growth were below the company's own trend. EBITDA margin rose 332 bps year on year. Revenue rose ₹108 cr on a year ago, against ₹130 cr the year before. Share price after the results: −10.2% in 30 days (Nifty 500: −3.8%).
  • Q3 FY26: Revenue ₹605 cr (+23% year on year), EBITDA ₹151 cr (+34% year on year), PAT ₹74.9 cr (+70% year on year), EBITDA margin 25.0% (+202 bps). Score 68 of 100, Above trend. Revenue growth was above the company's own trend; EBITDA and profit growth were below it. EBITDA margin rose 202 bps year on year. Revenue fell 11% from last quarter. Revenue rose ₹114 cr on a year ago, more than the ₹87.0 cr it added the year before. Share price after the results: +5.3% in 30 days (Nifty 500: −6.9%).
  • Q2 FY26: Revenue ₹679 cr (+27% year on year), EBITDA ₹182 cr (+64% year on year), PAT ₹90.0 cr (+100% year on year), EBITDA margin 26.8% (+598 bps). Score 82 of 100, Above trend. Revenue growth was well above the company's own trend; EBITDA growth was in line with it; profit growth was below it. EBITDA margin rose 598 bps year on year. Revenue rose ₹146 cr on a year ago, more than the ₹78.0 cr it added the year before. Share price after the results: +7.3% in 30 days (Nifty 500: +0.7%).
  • Q1 FY26: Revenue ₹559 cr (+20% year on year), EBITDA ₹132 cr (+40% year on year), PAT ₹58.0 cr (+87% year on year), EBITDA margin 23.6% (+335 bps). Score 65 of 100, Above trend. Revenue growth was above the company's own trend; EBITDA and profit growth were below it. EBITDA margin rose 335 bps year on year. Revenue fell 9% from last quarter. Revenue rose ₹95.0 cr on a year ago, more than the ₹55.0 cr it added the year before. Share price after the results: −13.4% in 28 days (Nifty 500: −2.0%).
  • Q4 FY25: Revenue ₹614 cr (+27% year on year), EBITDA ₹133 cr (+46% year on year), PAT ₹64.0 cr (+100% year on year), EBITDA margin 21.7% (+286 bps). Score 74 of 100, Above trend. Revenue growth was well above the company's own trend; EBITDA and profit growth were below it. EBITDA margin rose 286 bps year on year. Revenue grew on the previous quarter, against its usual seasonal pattern. Share price after the results: +13.4% in 30 days (Nifty 500: +3.8%).
  • Q3 FY25: Revenue ₹491 cr (+22% year on year), EBITDA ₹113 cr (+27% year on year), PAT ₹44.0 cr (+52% year on year), EBITDA margin 23.0% (+98 bps). Score 65 of 100, Above trend. Revenue growth was above the company's own trend; EBITDA growth was below it. EBITDA margin rose 98 bps year on year. Revenue fell 8% from last quarter.

Past price moves after results do not indicate future moves. Not a recommendation.

Privi Speciality Chemicals Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.